LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, ...

Time for Defensive ETFs on Renewed Trump Tariff Threats?

Renewed Trump tariff threats hit markets hard on Oct. 10, 2025. Defensive plays like BTAL, HDGE, CTA, and KMLM outperformed S ...